Bouza E, Hortal J, Muñoz P, Pérez M J, Riesgo M J, Hiesmayr M
Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
J Hosp Infect. 2006 Aug;63(4):399-405. doi: 10.1016/j.jhin.2006.03.007. Epub 2006 Jun 15.
Patients undergoing major heart surgery (MHS) may be at increased risk for nosocomial infections. To assess the incidence and type of infections in MHS patients in European intensive care units (ICUs) and their quality of care, a questionnaire was sent to a selection of MHS ICUs in Europe. Seventeen hospitals from seven European countries participated. Overall, 53% of the ICUs received patients only for MHS and the other 47% were mixed. During the study period, 11 915 patients underwent MHS and 1181 (9.9%) developed one or more nosocomial infections. Ventilator-associated pneumonia (VAP) was the most common infection [median 3.8%; interquartile range (IQR) 1.8-4.9], followed by surgical wound infection (median 1.6%; IQR 0.8-2.3), catheter-related bloodstream infection (median 1.3%; IQR 0.8-2.1), mediastinitis (median 1.1%; IQR 0.4-1.6), urinary tract infection (median 0.6; IQR 0.4-1.4) and nosocomial endocarditis (median 0.2%; IQR 0.0-0.9). Median mortality was 4.7% (IQR 2.7-8.4) and median infection-related mortality was 1% (IQR 0.5-2.7). Regarding VAP, 18% of the ICUs did not routinely pursue a diagnosis. Microbiological information was quantitative in 35% of cases and exclusively qualitative in 65% of cases. An infectious disease specialist was regularly involved in VAP management in only 35% of the ICUs, and the therapeutic approach to VAP involved de-escalation in 59% of the ICUs. MHS ICUs in Europe still have a high rate of postoperative infections. Well-recognized routine practices for the diagnosis and treatment of VAP are not implemented regularly in many European institutions.
接受心脏大手术(MHS)的患者发生医院感染的风险可能会增加。为了评估欧洲重症监护病房(ICU)中MHS患者的感染发生率、感染类型及其护理质量,向欧洲部分MHS ICU发送了一份调查问卷。来自七个欧洲国家的17家医院参与了调查。总体而言,53%的ICU仅接收接受MHS的患者,另外47%为混合型。在研究期间,11915例患者接受了MHS,其中1181例(9.9%)发生了一种或多种医院感染。呼吸机相关性肺炎(VAP)是最常见的感染[中位数为3.8%;四分位间距(IQR)为1.8 - 4.9],其次是手术伤口感染(中位数为1.6%;IQR为0.8 - 2.3)、导管相关血流感染(中位数为1.3%;IQR为0.8 - 2.1)、纵隔炎(中位数为1.1%;IQR为0.4 - 1.6)、尿路感染(中位数为0.6;IQR为0.4 - 1.4)和医院感染性心内膜炎(中位数为0.2%;IQR为0.0 - 0.9)。中位死亡率为4.7%(IQR为2.7 - 8.4),中位感染相关死亡率为1%(IQR为0.5 - 2.7)。关于VAP,18%的ICU未常规进行诊断。35%的病例微生物学信息为定量,65%的病例仅为定性。只有35%的ICU有感染病专科医生定期参与VAP管理,59%的ICU对VAP的治疗方法涉及降阶梯治疗。欧洲的MHS ICU术后感染率仍然很高。许多欧洲机构并未定期实施公认的VAP诊断和治疗常规做法。